SLXN
Silexion Therapeutics Corp
Price Chart
Latest Quote
$0.15
-0.01 (-7.54%)
Current Price
| Previous Close | $0.17 |
| Open | $0.17 |
| Day High | $0.17 |
| Day Low | $0.15 |
| Volume | 378,897 |
Stock Information
| Shares Outstanding | 14.47M |
| Total Debt | $1.41M |
| Cash Equivalents | $2.23M |
| Net Income | $-13.96M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $2.22M |
| EPS (TTM) | $-27.21 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $33K |
| Income | $-13.96M |
| Book/sh | $0.01 |
| Cash/sh | $0.15 |
| Employees | 13 |
Financial Ratios
| Quick Ratio | 0.56 |
| Current Ratio | 0.94 |
| Debt/Eq | 3204.55 |
Returns & Margins
Ownership
| Insider Ownership | 14.67% |
| Institutional Ownership | 0.32% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -0.24 |
| P/B | 19.15 |
Analyst Data
| Recommendation | none |
| Target Price | $5.00 |
Technical Indicators
| SMA20 | $0.20 |
| SMA50 | $0.29 |
| SMA200 | $6.90 |
| RSI | 28.42 |
| ATR | 0.0266 |
| Shares Float | 5.56M |
| Short Float | 1.30% |
| Short Ratio | 0.01 |
| Volatility | -0.30 |
| Rel Volume | 0.27 |
Performance History
| Week | -7.27% |
| Month | -51.89% |
| Quarter | -91.68% |
| 6 Months | -97.58% |
| YTD | -99.19% |
| Year | -99.56% |
| 3 Years | -99.99% |
| 5 Years | -99.99% |
| 10 Years | -99.99% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-10-28 | $0.15 | 457,300 |
| 2026-10-27 | $0.17 | 975,400 |
| 2026-10-26 | $0.17 | 3,418,100 |
| 2026-10-23 | $0.19 | 2,811,800 |
| 2026-10-22 | $0.17 | 544,900 |
| 2026-10-21 | $0.17 | 286,900 |
| 2026-10-20 | $0.15 | 1,119,100 |
| 2026-10-19 | $0.15 | 5,121,200 |
| 2026-10-16 | $0.15 | 831,600 |
| 2026-10-15 | $0.19 | 2,829,200 |
| 2026-10-14 | $0.17 | 704,900 |
| 2026-10-13 | $0.18 | 2,087,900 |
| 2026-10-12 | $0.18 | 1,268,800 |
| 2026-10-09 | $0.22 | 821,100 |
| 2026-10-08 | $0.23 | 1,512,500 |
| 2026-10-07 | $0.25 | 1,075,200 |
| 2026-10-06 | $0.26 | 999,300 |
| 2026-10-05 | $0.27 | 1,234,000 |
| 2026-10-02 | $0.26 | 2,025,100 |
| 2026-10-01 | $0.28 | 3,304,100 |
| 2026-09-30 | $0.28 | 11,701,000 |
| 2026-09-29 | $0.32 | 256,569,000 |
About Silexion Therapeutics Corp
Silexion Therapeutics Corp, a clinical-stage biotechnology company, discovers and develops RNA interference (RNAi) therapies for KRAS-driven cancers. Its products comprise SIL204 second-generation small interfering RNA (siRNA) undergoing phase 2/3 clinical evaluation for pancreatic cancer and silence mutant KRAS oncogene expression. The company was founded in 2008 and is headquartered in Ramat Gan, Israel.
đ° Latest News
No news articles available at the moment. Check back later for updates on SLXN.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Interest Expense | $13,000 | $7,000 | $6,000 | - |
| Total Expenses | $11,632,000 | $12,571,000 | $4,681,000 | $3,860,000 |
| Rent Expense Supplemental | $177,000 | $89,000 | $86,000 | $71,000 |
| Other Income Expense | $-406,000 | $903,000 | $-539,000 | $367,000 |
| Other Non Operating Income Expenses | $-279,000 | $1,150,000 | $-86,000 | $1,017,000 |
| Net Non Operating Interest Income Expense | $129,000 | $-4,841,000 | $144,000 | $29,000 |
| Interest Expense Non Operating | $13,000 | $7,000 | $6,000 | - |
| Operating Expense | $11,632,000 | $12,571,000 | $4,681,000 | $3,860,000 |
| General And Administrative Expense | $4,478,000 | $6,731,000 | $928,000 | $577,000 |
| Total Other Finance Cost | - | $4,835,000 | $3,000 | $85,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-11,912,000 | $-16,443,000 | $-4,942,000 | $-3,215,000 |
| Net Interest Income | $129,000 | $-4,841,000 | $144,000 | $29,000 |
| Interest Income | $142,000 | $1,000 | $153,000 | $114,000 |
| Normalized Income | $-11,814,210 | $-16,252,810 | $-4,593,190 | $-2,714,500 |
| Net Income From Continuing And Discontinued Operation | $-11,912,000 | $-16,443,000 | $-4,942,000 | $-3,215,000 |
| Total Operating Income As Reported | $11,632,000 | $12,571,000 | $-4,681,000 | $-3,860,000 |
| Net Income Common Stockholders | $-11,912,000 | $-16,443,000 | $-4,942,000 | $-3,215,000 |
| Net Income | $-11,912,000 | $-16,443,000 | $-4,942,000 | $-3,215,000 |
| Net Income Including Noncontrolling Interests | $-11,912,000 | $-16,519,000 | $-5,108,000 | $-3,488,000 |
| Net Income Continuous Operations | $-11,912,000 | $-16,519,000 | $-5,108,000 | $-3,488,000 |
| Pretax Income | $-11,909,000 | $-16,509,000 | $-5,076,000 | $-3,464,000 |
| Interest Income Non Operating | $142,000 | $1,000 | $153,000 | $114,000 |
| Operating Income | $-11,632,000 | $-12,571,000 | $-4,681,000 | $-3,860,000 |
| Depreciation Amortization Depletion Income Statement | $14,000 | $25,000 | $45,000 | $57,000 |
| Depreciation And Amortization In Income Statement | $14,000 | $25,000 | $45,000 | $57,000 |
| Depreciation Income Statement | $14,000 | $25,000 | $45,000 | $57,000 |
| Per Share | ||||
| Diluted EPS | $-89.60 | $-3949.40 | $-818.48 | $-532.46 |
| Basic EPS | $-89.60 | $-3949.40 | $-818.48 | $-532.46 |
| Other | ||||
| Tax Effect Of Unusual Items | $-29,210 | $-56,810 | $-104,190 | $-149,500 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-11,755,000 | $-16,230,000 | $-4,572,000 | $-3,153,000 |
| Total Unusual Items | $-127,000 | $-247,000 | $-453,000 | $-650,000 |
| Total Unusual Items Excluding Goodwill | $-127,000 | $-247,000 | $-453,000 | $-650,000 |
| Reconciled Depreciation | $14,000 | $25,000 | $45,000 | $57,000 |
| EBITDA (Bullshit earnings) | $-11,882,000 | $-16,477,000 | $-5,025,000 | $-3,803,000 |
| EBIT | $-11,896,000 | $-16,502,000 | $-5,070,000 | $-3,860,000 |
| Diluted Average Shares | $132,951 | $4,163 | $6,038 | $6,038 |
| Basic Average Shares | $132,951 | $4,163 | $6,038 | $6,038 |
| Diluted NI Availto Com Stockholders | $-11,912,000 | $-16,443,000 | $-4,942,000 | $-3,215,000 |
| Minority Interests | $0 | $76,000 | $166,000 | $273,000 |
| Tax Provision | $3,000 | $10,000 | $32,000 | $24,000 |
| Gain On Sale Of Security | $-127,000 | $-247,000 | $-453,000 | $-650,000 |
| Research And Development | $7,140,000 | $5,815,000 | $3,708,000 | $3,226,000 |
| Selling General And Administration | $4,478,000 | $6,731,000 | $928,000 | $577,000 |
| Other Gand A | $2,640,000 | $2,050,000 | $486,000 | $287,000 |
| Rent And Landing Fees | $177,000 | $89,000 | $86,000 | $71,000 |
| Salaries And Wages | $1,661,000 | $4,592,000 | $356,000 | $219,000 |
Fetched: 2026-10-24
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $2,603,000 | $-3,989,000 | $-15,476,000 | $-10,665,000 |
| Total Assets | $7,215,000 | $2,863,000 | $5,256,000 | $9,333,000 |
| Total Non Current Assets | $578,000 | $613,000 | $277,000 | $494,000 |
| Other Non Current Assets | $57,000 | $48,000 | $25,000 | $25,000 |
| Non Current Prepaid Assets | $84,000 | $5,000 | $5,000 | $5,000 |
| Current Assets | $6,637,000 | $2,250,000 | $4,979,000 | $8,839,000 |
| Other Current Assets | $49,000 | $62,000 | $24,000 | $42,000 |
| Restricted Cash | $27,000 | $35,000 | $25,000 | $25,000 |
| Prepaid Assets | $570,000 | $966,000 | $335,000 | $513,000 |
| Cash Cash Equivalents And Short Term Investments | $5,991,000 | $1,187,000 | $4,595,000 | $8,259,000 |
| Cash And Cash Equivalents | $5,991,000 | $1,187,000 | $4,595,000 | $8,259,000 |
| Debt | ||||
| Total Debt | $2,036,000 | $4,491,000 | $171,000 | $271,000 |
| Long Term Debt And Capital Lease Obligation | $1,854,000 | $3,329,000 | $59,000 | $156,000 |
| Long Term Debt | $1,568,000 | $2,961,000 | - | - |
| Current Debt And Capital Lease Obligation | $182,000 | $1,162,000 | $112,000 | $115,000 |
| Net Debt | - | $2,778,000 | - | - |
| Current Debt | - | $1,004,000 | - | - |
| Other Current Borrowings | - | $1,004,000 | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $4,612,000 | $6,852,000 | $17,312,000 | $16,412,000 |
| Total Non Current Liabilities Net Minority Interest | $1,854,000 | $3,329,000 | $15,116,000 | $14,802,000 |
| Current Liabilities | $2,758,000 | $3,523,000 | $2,196,000 | $1,610,000 |
| Payables And Accrued Expenses | $1,697,000 | $1,717,000 | $1,677,000 | $1,239,000 |
| Payables | $838,000 | $976,000 | $319,000 | $240,000 |
| Total Tax Payable | $51,000 | $47,000 | - | - |
| Income Tax Payable | $51,000 | $47,000 | - | - |
| Accounts Payable | $787,000 | $929,000 | $319,000 | $240,000 |
| Other Current Liabilities | - | $2,000 | $200,000 | $3,000 |
| Equity | ||||
| Common Stock Equity | $2,603,000 | $-3,989,000 | $-15,476,000 | $-10,665,000 |
| Total Equity Gross Minority Interest | $2,603,000 | $-3,989,000 | $-12,056,000 | $-7,079,000 |
| Stockholders Equity | $2,603,000 | $-3,989,000 | $-15,476,000 | $-10,665,000 |
| Retained Earnings | $-55,166,000 | $-43,254,000 | $-26,811,000 | $-21,869,000 |
| Preferred Securities Outside Stock Equity | - | $0 | $15,057,000 | $14,646,000 |
| Other | ||||
| Ordinary Shares Number | $312,665 | $12,324 | $6,038 | $6,038 |
| Share Issued | $312,665 | $12,326 | $6,038 | $6,038 |
| Tangible Book Value | $2,603,000 | $-3,989,000 | $-15,476,000 | $-10,665,000 |
| Invested Capital | $4,171,000 | $-24,000 | $-15,476,000 | $-10,665,000 |
| Working Capital | $3,879,000 | $-1,273,000 | $2,783,000 | $7,229,000 |
| Capital Lease Obligations | $468,000 | $526,000 | $171,000 | $271,000 |
| Total Capitalization | $4,171,000 | $-1,028,000 | $-15,476,000 | $-10,665,000 |
| Additional Paid In Capital | $57,727,000 | $39,263,000 | $11,335,000 | $11,203,000 |
| Capital Stock | $42,000 | $2,000 | $0 | $1,000 |
| Common Stock | $42,000 | $2,000 | $0 | $1,000 |
| Long Term Capital Lease Obligation | $286,000 | $368,000 | $59,000 | $156,000 |
| Current Capital Lease Obligation | $182,000 | $158,000 | $112,000 | $115,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $879,000 | $642,000 | $207,000 | $253,000 |
| Current Accrued Expenses | $859,000 | $741,000 | $1,358,000 | $999,000 |
| Net PPE | $437,000 | $560,000 | $247,000 | $464,000 |
| Accumulated Depreciation | $-83,000 | $-69,000 | $-87,000 | $-239,000 |
| Gross PPE | $520,000 | $629,000 | $247,000 | $703,000 |
| Other Properties | $412,000 | $530,000 | $247,000 | $582,000 |
| Machinery Furniture Equipment | $108,000 | $99,000 | $77,000 | $69,000 |
| Treasury Shares Number | - | $2 | - | - |
| Minority Interest | - | $0 | $3,420,000 | $3,586,000 |
| Leases | - | $0 | $56,000 | $52,000 |
| Properties | - | $0 | $0 | $0 |
Fetched: 2026-10-24
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-10,828,000 | $-8,418,000 | $-4,541,000 | $-3,375,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-10,819,000 | $-8,396,000 | $-4,529,000 | $-3,335,000 |
| Cash Flow From Continuing Operating Activities | $-10,819,000 | $-8,396,000 | $-4,529,000 | $-3,335,000 |
| Operating Gains Losses | - | $16,000 | $-1,000 | - |
| Investing Activities | ||||
| Capital Expenditure | $-9,000 | $-22,000 | $-12,000 | $-40,000 |
| Investing Cash Flow | $-14,000 | $-22,000 | $573,000 | $-524,000 |
| Cash Flow From Continuing Investing Activities | $-14,000 | $-22,000 | $573,000 | $-524,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $18,680,000 | $3,054,000 | $522,000 | $2,749,000 |
| Financing Cash Flow | $15,640,000 | $5,104,000 | $522,000 | $2,752,000 |
| Cash Flow From Continuing Financing Activities | $15,640,000 | $5,104,000 | $522,000 | $2,752,000 |
| Net Other Financing Charges | $-2,344,000 | $2,300,000 | - | - |
| Net Preferred Stock Issuance | $2,644,000 | $0 | $522,000 | $2,749,000 |
| Preferred Stock Issuance | $2,644,000 | $0 | $522,000 | $2,749,000 |
| Net Common Stock Issuance | $16,036,000 | $3,054,000 | $0 | - |
| Common Stock Issuance | $16,036,000 | $3,054,000 | $0 | - |
| Other | ||||
| Repayment Of Debt | $-696,000 | $-250,000 | $0 | - |
| Interest Paid Supplemental Data | $13,000 | $27,000 | - | - |
| End Cash Position | $6,075,000 | $1,270,000 | $4,645,000 | $8,309,000 |
| Beginning Cash Position | $1,270,000 | $4,645,000 | $8,309,000 | $10,083,000 |
| Effect Of Exchange Rate Changes | $-2,000 | $-61,000 | $-230,000 | $-667,000 |
| Changes In Cash | $4,807,000 | $-3,314,000 | $-3,434,000 | $-1,107,000 |
| Net Issuance Payments Of Debt | $-696,000 | $-250,000 | $0 | - |
| Net Long Term Debt Issuance | $-696,000 | $-250,000 | $0 | - |
| Long Term Debt Payments | $-696,000 | $-250,000 | $0 | - |
| Net Investment Purchase And Sale | $-5,000 | $0 | $507,000 | $-484,000 |
| Purchase Of Investment | $-5,000 | $0 | $0 | $-500,000 |
| Net PPE Purchase And Sale | $-9,000 | $-22,000 | $66,000 | $-40,000 |
| Purchase Of PPE | $-9,000 | $-22,000 | $-12,000 | $-40,000 |
| Change In Working Capital | $601,000 | $-1,580,000 | $87,000 | $239,000 |
| Change In Other Working Capital | $232,000 | $378,000 | $-40,000 | $-87,000 |
| Change In Other Current Assets | $13,000 | $-38,000 | $18,000 | - |
| Change In Payables And Accrued Expense | $-40,000 | $-1,289,000 | $438,000 | $-49,000 |
| Change In Accrued Expense | $102,000 | $-1,899,000 | $359,000 | $-11,000 |
| Change In Payable | $-142,000 | $610,000 | $79,000 | $-38,000 |
| Change In Account Payable | $-142,000 | $610,000 | $79,000 | $-38,000 |
| Change In Prepaid Assets | $396,000 | $-631,000 | $-329,000 | $415,000 |
| Other Non Cash Items | $344,000 | $3,800,000 | $318,000 | $-268,000 |
| Stock Based Compensation | $134,000 | $5,862,000 | $130,000 | $125,000 |
| Depreciation Amortization Depletion | $14,000 | $25,000 | $45,000 | $57,000 |
| Depreciation And Amortization | $14,000 | $25,000 | $45,000 | $57,000 |
| Depreciation | $14,000 | $25,000 | $45,000 | $57,000 |
| Gain Loss On Sale Of PPE | $0 | $16,000 | $-1,000 | $0 |
| Net Income From Continuing Operations | $-11,912,000 | $-16,519,000 | $-5,108,000 | $-3,488,000 |
| Sale Of Investment | - | $0 | $507,000 | $16,000 |
| Sale Of PPE | - | $0 | $78,000 | $0 |
| Proceeds From Stock Option Exercised | - | - | $0 | $3,000 |
| Change In Receivables | - | - | $18,000 | $-40,000 |
Fetched: 2026-10-24